PT Bundamedik Tbk (IDX:BMHS)

PT Bundamedik Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,528,004	1,554,685	1,488,197	1,658,688	1,890,800	1,148,144
Revenue Growth (YoY)	-1.48%	4.47%	-10.28%	-12.28%	64.68%	18.99%
Cost of Revenue	863,007	866,846	813,590	915,848	942,939	679,913
Gross Profit	664,997	687,839	674,607	742,840	947,861	468,231
Selling, General & Admin	467,478	471,154	463,169	415,685	405,196	249,243
Other Operating Expenses	15,931	15,032	10,176	2,196	-3,721	-6,891
Operating Expenses	597,108	599,885	586,899	526,419	472,885	300,642
Operating Income	67,889	87,953	87,709	216,422	474,976	167,590
Interest Expense	-65,609	-64,703	-53,290	-42,694	-20,031	-43,633
Interest & Investment Income	23,196	18,641	8,424	8,363	10,178	4,734
Earnings From Equity Investments	-	-	-	-	-	25,816
Other Non Operating Income (Expenses)	-2,502	-3,350	-4,473	-4,425	-7,984	-9,486
EBT Excluding Unusual Items	22,973	38,541	38,369	177,665	457,139	145,020
Gain (Loss) on Sale of Assets	52.94	52.94	1,954	-874.84	-	-28.33
Pretax Income	23,026	38,594	40,323	176,790	457,139	144,992
Income Tax Expense	16,382	19,698	24,094	47,858	102,490	26,532
Earnings From Continuing Operations	6,644	18,896	16,229	128,932	354,649	118,460
Minority Interest in Earnings	-1,762	-6,952	-8,768	-45,704	-140,160	-29,669
Net Income	4,883	11,944	7,461	83,228	214,489	88,791
Net Income to Common	4,883	11,944	7,461	83,228	214,489	88,791
Net Income Growth	-65.53%	60.08%	-91.03%	-61.20%	141.57%	346.31%
Shares Outstanding (Basic)	8,603	8,603	8,603	8,603	8,603	2,077
Shares Outstanding (Diluted)	8,603	8,603	8,603	8,603	8,603	2,077
Shares Change (YoY)	-	-	-	-	314.14%	4054.80%
EPS (Basic)	0.57	1.39	0.87	9.67	24.93	42.74
EPS (Diluted)	0.57	1.39	0.87	9.67	24.93	42.74
EPS Growth	-65.53%	60.08%	-91.03%	-61.20%	-41.67%	-89.26%
Free Cash Flow	-118,988	-202,046	-157,915	-170,646	51,263	140,752
Free Cash Flow Per Share	-13.83	-23.48	-18.36	-19.84	5.96	67.75
Dividend Per Share	0.650	0.650	0.560	1.500	2.557	-
Dividend Growth	16.07%	16.07%	-62.67%	-41.34%	-	-
Gross Margin	43.52%	44.24%	45.33%	44.79%	50.13%	40.78%
Operating Margin	4.44%	5.66%	5.89%	13.05%	25.12%	14.60%
Profit Margin	0.32%	0.77%	0.50%	5.02%	11.34%	7.73%
Free Cash Flow Margin	-7.79%	-13.00%	-10.61%	-10.29%	2.71%	12.26%
EBITDA	157,036	183,039	182,468	306,066	537,580	223,186
EBITDA Margin	10.28%	11.77%	12.26%	18.45%	28.43%	19.44%
D&A For EBITDA	89,148	95,085	94,759	89,644	62,604	55,596
EBIT	67,889	87,953	87,709	216,422	474,976	167,590
EBIT Margin	4.44%	5.66%	5.89%	13.05%	25.12%	14.60%
Effective Tax Rate	71.14%	51.04%	59.75%	27.07%	22.42%	18.30%
Advertising Expenses	-	25,315	26,906	31,959	33,182	9,925

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.